Labs in Court

Subscribe today for access to
Articles and Reports

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024

By Karen Lovitch, Laura Martin | Dec 3, 2024 | 1 min read

Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters

By Danielle Sloane, Morgan Tandy | Oct 28, 2024 | 1 min read

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

By Glenn S. Demby | Sep 25, 2023 | 1 min read

Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.

By Glenn S. Demby | Aug 31, 2023 | 1 min read

In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.

By Glenn S. Demby | Jul 31, 2023 | 1 min read

Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.

By Glenn S. Demby | Jul 4, 2023 | 1 min read

Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.

By Glenn S. Demby | May 31, 2023 | 1 min read

In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.

By Glenn S. Demby | Jan 27, 2023 | 1 min read

In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.